The role of antioxidants in multiple myeloma: diagnostic, prognostic, and therapeutic applications: a narrative review
Therapeutic Advances in Hematology
Published online on February 19, 2026
Abstract
Therapeutic Advances in Hematology, Volume 17, January-December 2026.
Multiple myeloma (MM) is a B-cell malignancy involving monoclonal plasma cells that produce nonfunctional immunoglobulins. It is still incurable due to de novo or acquired resistance of malignant cells to standard chemotherapies. Thus, understanding the ...
Multiple myeloma (MM) is a B-cell malignancy involving monoclonal plasma cells that produce nonfunctional immunoglobulins. It is still incurable due to de novo or acquired resistance of malignant cells to standard chemotherapies. Thus, understanding the ...